A vs AMED: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Amedisys Inc in 2026
A
Agilent Technologies Inc
$120.39
AMED
Amedisys Inc
—
Key Metrics Comparison
| Metric | A | AMED | Winner |
|---|---|---|---|
| Market Cap | $34.05B | $3.32B | A |
| P/E Ratio | 25.89 | 39.30 | A |
| EPS (TTM) | $4.65 | $2.57 | A |
| Revenue Growth | 0.1% | 0.1% | A |
| Gross Margin | 52.3% | 43.2% | A |
Analyze A
Full quant analysis
Analyze AMED
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or AMED a better investment?
Comparing A and AMED: Agilent Technologies Inc has a market cap of $34.05B while Amedisys Inc has $3.32B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and AMED?
A (Agilent Technologies Inc) and AMED (Amedisys Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or AMED?
Based on P/E ratios, A trades at a lower multiple (25.9x vs 39.3x).
Which is growing faster: A or AMED?
A has higher revenue growth at 0.1% vs 0.1% for AMED.
Which company is more profitable: A or AMED?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 43.2% for AMED.
Which is the larger company: A or AMED?
Agilent Technologies Inc (A) is larger with a market cap of $34.05B compared to $3.32B for AMED.
Should I buy A or AMED in 2026?
Both A and AMED have investment merit. A trades at $120.39 while AMED trades at $N/A. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and AMED stock?
Key differences: Market Cap ($34.05B vs $3.32B), P/E Ratio (25.9x vs 39.3x), Revenue Growth (0.1% vs 0.1%), Gross Margin (52.3% vs 43.2%).